John Theurer Cancer Center, Hackensack UMC

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Acute myeloid leukaemia
• Bladder cancer
• Chronic lymphocytic leukaemia
• Chronic myeloid leukaemia
• Diffuse large B-cell lymphoma
• Follicular lymphoma
• Mantle cell lymphoma
• Multiple myeloma

Running trials

• Active, not recruiting

  Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.

  NCT03229200· Phase 4· Pharmacyclics Switzerland GmbH· Source